Our bodies response to invading pathogens through different mechanisms of the immune system. Innate immunity first detects ...

Plasma cells originate in lymphoid (immune) tissues and then migrate to protected sites throughout the body, where they produce large amounts of antibodies in response to infection-related substances.

Plasma cell leukemia (PCL) is a rare disease that may present de novoor secondary to plasma cell myeloma. Advanced disease and extramedullary involvement are common clinical features at presentation.

Oncologists are increasingly favoring CAR T-cell therapy’s early-line use in relapsed/refractory multiple myeloma despite ...

In a recent study published in the Journal of Experimental Medicine, a multi-institutional research team led by Osaka ...

EsoBiotec’s platform has the potential to eliminate the complex and time-consuming process for manufacturing, helping to make CAR-T cell therapies more accessible.

Last November, results from the MITIGATE trial made headlines at ACR Convergence 2024 with positive phase 3 trial data for inebilizumab, an IgG1 monoclonal antibody targeting CD19, in patients with ...

The knowledge of how thalidomide works helped scientists put the drug to use as a treatment for multiple myeloma, a cancer of plasma cells. HIV and AIDS. In the late 1980s, researchers discovered ...

In a study published today in the ExRNA journal, researchers from the Novosibirsk Institute of Chemical Biology and Fundamental Medicine have proved that pre-analytical variables, as blood plasma or ...

Solar cells convert sunlight into clean energy—but if the solar cells themselves are made of toxic materials, it almost ...